The Biden administration is expected to nominate John Nkengasong, director of the Africa CDC, to lead the President’s Emergency Plan for AIDS Relief in the coming days.   Nkengasong, a Cameroon-born virologist, would be the first person of African origin to head the US…

COVID-19 and the climate took center stage as the United Nations General Assembly opened up yesterday, under an honor system vaccination requirement for in-person attendees.   Nevertheless, it was Brazilian President Jair Bolsonaro—who reportedly isn’t…

60% of the 55 million families affected by Alzheimer’s globally live in low- and middle-income countries—yet the vast majority of genetic research on the disease has been limited to westerners.

South Africa’s sugar tax is working, reducing sugary drink purchases by 28% since 2018, offering a key means to address the country’s sky-high levels of diabetes and obesity.  But still:

Possible ancestors of SARS-CoV-2 have been found in 3 coronaviruses in horseshoe bats that inhabit limestone caves in northern Laos, according to a not-yet-peer-reviewed article by Laotian and French researchers.  

With 12,000+ migrants congregating near a Texas-Mexico bridge, the US has taken aggressive steps to deter future migrants.

Rising sea levels, water scarcity and declining crop productivity could displace 216 million people within their own countries by 2050—hitting the world’s poorest countries the hardest, a World Bank report released this week shows.    

Indoor residual spraying of insecticides is a tried-and-true method of malaria control—but a costly one, making scalability and sustainability a challenge. A new study of An. gambiae mosquitoes in 8 communities in northern Ghana found that partial spraying—targeting only…

Chile’s well-tuned vaccination campaign is an exemplar for wealthy countries and the rest of the world. 87% of eligible Chileans have been vaccinated. It has 36 million doses for its population of 19 million. It’s also approved vaccinations for children ages 6 to…

Emerging data show the Moderna vaccine may retain higher effectiveness over Pfizer’s as months go by, but experts caution that it’s still early days and the comparisons may be flawed, Axios reports.